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Abstract
Background: After seven annual rounds of mass drug administration (MDA) in six Malian villages highly endemic
for Wuchereria bancrofti (overall prevalence rate of 42.7%), treatment was discontinued in 2008. Surveillance was
performed over the ensuing 5 years to detect recrudescence.
Methods: Circulating filarial antigen (CFA) was measured using immunochromatographic card tests (ICT) and
Og4C3 ELISA in 6–7 year-olds. Antibody to the W. bancrofti infective larval stage (L3) antigen, Wb123, was tested in
the same population in 2012. Microfilaraemia was assessed in ICT-positive subjects. Anopheles gambiae complex
specimens were collected monthly using human landing catch (HLC) and pyrethrum spray catch (PSC). Anopheles
gambiae complex infection with W. bancrofti was determined by dissection and reverse transcriptase polymerase
chain reaction (RT-PCR) of mosquito pools.
Results: Annual CFA prevalence rates using ICT in children increased over time from 0% (0/289) in 2009 to 2.
7% (8/301) in 2011, 3.9% (11/285) in 2012 and 4.5% (14/309) in 2013 (trend χ2 = 11.85, df =3, P = 0.0006).
Wb123 antibody positivity rates in 2013 were similar to the CFA prevalence by ELISA (5/285). Although two
W. bancrofti-infected Anopheles were observed by dissection among 12,951 mosquitoes collected by HLC,
none had L3 larvae when tested by L3-specific RT-PCR. No positive pools were detected among the
mosquitoes collected by pyrethrum spray catch. Whereas ICT in 6–7 year-olds was the major surveillance tool,
ICT positivity was also assessed in older children and adults (8–65 years old). CFA prevalence decreased in
this group from 4.9% (39/800) to 3.5% (28/795) and 2.8% (50/1,812) in 2009, 2011 and 2012, respectively
(trend χ2 = 7.361, df =2, P = 0.0067). Some ICT-positive individuals were microfilaraemic in 2009 [2.6% (1/39)]
and 2011 [8.3% (3/36)], but none were positive in 2012 or 2013.
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Conclusion: Although ICT rates in children increased over the 5-year surveillance period, the decrease in ICT
prevalence in the older group suggests a reduction in transmission intensity. This was consistent with the
failure to detect infective mosquitoes or microfilaraemia. The threshold of ICT positivity in children may need
to be re-assessed and other adjunct surveillance tools considered.
Keywords: Wuchereria bancrofti, Transmission assessment survey, Anopheles gambiae complex, Mass drug
administration, Post-MDA surveillance
Background
Lymphatic filariasis (LF) is a public health problem in 71
countries and is associated with marked morbidity and
disability [1]. To eliminate LF by 2020, the Global Pro-
gram to Eliminate LF (GPELF) adopted strategies based
on two pillars: annual mass drug administration (MDA)
to all eligible residents of the endemic communities and
morbidity management [2]. MDA is aimed at interrupt-
ing LF transmission through clearing of peripheral blood
microfilariae that prevent human-to-human vector-
borne transmission [2].
As Bancroftian filariasis was found to be endemic
in all eight administrative districts of Mali, ranging
from 1% in Timbuktu (northern part of Mali)
to > 18% in Sikasso (southern part of the country)
[3], annual MDA using ivermectin and albendazole
was initiated sequentially starting from the most
highly endemic district in the country [3]. Sentinel
sites were established in Sikasso as part of a multi-
country initiative to assess LF transmission during
and after stopping MDA. The baseline data and the
impact of six rounds of MDA on human infection
and potential transmission in this sentinel site have
been previously reported [4].
The current study reports data collected to assess
transmission after MDA was stopped in 2007 (after
seven rounds of MDA). Although this study was initi-
ated prior to the formal WHO recommendations for
transmission assessment surveys (TAS), which require
demonstration of an infection rate of < 1% in > 400
children aged 6–7 years using the immunochromato-
graphic card test (ICT) to document interruption of
transmission [5], a similar approach was taken using
ICT testing of children aged 6–7 years. ICT testing of a
cohort of children ≥ 8 years old and adults and ento-
mological assessment of LF transmission were per-
formed. Finally, the use of several additional methods
(Og4C3 ELISA; Polymerase Chain Reaction (PCR) tar-
geting Wuchereria bancrofti DNA; and W. bancrofti in-
fective larval stage specific antigen Wb123-based IgG4
immunoassays) to assess transmission interruption in
this previously highly LF-endemic region (Sikasso) of




The study area comprised six villages in Sikasso district:
Gondaga, Dozanso, Missasso, N’torla, Niatanso and Zana-
dougou. These villages are located in the rural commune
of Kolokoba that is located 332 km southeast of Bamako
the capital city. Wuchereria bancrofti infection prevalence
as assessed by the detection of CFA using ICT prior to
MDA was 46% [4]. This area is also endemic for Manso-
nella perstans, but not Onchocerca volvulus infection.
Based on 2012 census data, the total population of the 6
villages was 5044. The study villages had undergone 7
annual rounds of MDA prior to its cessation in 2008, at
which time the CFA prevalence had decreased to 0/760
children tested and the Anopheles gambiae complex mos-
quitoes showed an infection rate of 0.04% and an infectiv-
ity rate of 0.02% that were felt to be incompatible with
active LF transmission [6]. There was a mean program-
matic coverage rate based on the total population of
75.6% that varied from 67 to 78% [6]. A year after cessa-
tion of MDA (in 2009), no infected 6–7 year-old children
were found among the 120 tested in the six villages.
Study design
As post-MDA surveillance, a yearly cross-sectional para-
sitological assessment of all children 6–7 years of age
and all eligible older volunteers aged 8 years and above
was performed in July from 2009 to 2012. In addition, a
monthly entomological assessment of LF transmission
(from July to December) was conducted in the six study
villages in 2009, 2011 and 2013. In 2013, only children
aged 6–7 years were tested with the ICT, along with a
thick smear from night blood. Infective stage W. bancrofti
larvae (L3) were assessed in mosquitoes using an L3-
specific reverse transcriptase PCR (RT-PCR) technique as
previously described [7]. The study design is illustrated in
Fig. 1. EVAL refers to the ensemble of surveillance testing
performed in any given year.
Parasitological and serological assessments
Infection status was assessed using the ICT card test for
the detection of circulating W. bancrofti antigen (Allere,
Portland, ME, USA). Dried blood spots were collected
for additional laboratory analyses. Microfilaraemia was
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assessed by finger prick at night (between 22:00 and
02:00 h) among ICT-positive volunteers using a cali-
brated thick smear. Yearly parasitological studies were
conducted in July, at the beginning of the transmission
period, except in 2009 when, for logistical reasons, this
assessment was performed in October. Because of the
concern of potential transmission, additional diagnostic
tests were performed on eluted blood spots from the 6–7
year-old children in 2012, namely the Og4C3 ELISA
(Tropbio Townsville, Australia) and ELISA testing for
antibodies to Wb123 as previously described [8].
Entomological assessment
Each month, a 12-day entomological survey was con-
ducted in the six villages to assess the village wide W.
bancrofti transmission patterns during the LF transmis-
sion period in Mali from July to December [4]. Two
human landing catch (HLC) sessions were organized per
month and per village. Two collectors worked inside
each of four collection rooms per session.
Because An. gambiae is endophilic, collections were
performed indoors to maximize yield. A total of 72
collection rounds were undertaken with the HLC. The
collection was done from 18:00 to 06:00 h, and for
ethical reasons, the collectors were replaced at midnight
at each collection site. All An. gambiae and An. funestus
complexes collected were freshly dissected for parity
status based on techniques previously described [9, 10]
and for infection (any larval stage) and infectivity (L3
stage) status by individual mosquito dissection as previ-
ously described [11].
In 2012, the PSC (Pyrethrum Spray Catch) was used to
collect mosquito vectors in addition to the HLC using
Premium®, a pyrethrinoid-based insecticide, in 30 ran-
domly selected rooms per village in each of the six
collection months. During each of the 36 PSC collection
rounds, the number of persons sleeping in each visited
room was recorded on the mosquito collection sheet.
The collected mosquitoes during the PSC were pooled
(1 to 20 mosquitoes) in the field and stored in tubes
containing RNA later and sent to Smith College for
W. bancrofti RNA detection by RT-PCR as previously
described [7].
For PSC, the monthly biting rate was determined by
dividing the number of fed and half-gravid female
Anopheles collected in a room by the number of sleepers
in the room the night before the collection multiplied by
30 [12]. The annual biting rate (ABR) was the sum of all
the monthly biting rates calculated over the year [12].
From HLC-collected Anopheles, the parameters were
determined as previously reported [12, 13].
Sampling
The present study predated the official WHO guidelines
for TAS [5]. Because the evaluation unit was small (<300
children aged 6–7 years), all of the available eligible chil-
dren were screened.
Data analysis
The collected data were entered using Microsoft Access
2007 and analysed using Graph Pad prism version 5 and
Statistical Package for Social Sciences (SPSS) version 20.
To compare the infection prevalences between villages or
mosquito species, we used the Pearson χ2 or the Fisher’s
exact test, if necessary. The trend χ2 was used to test the




We assessed 289 children aged 6–7 years in 2009, 301
in 2011, 285 in 2012 and 309 in 2013. Concomitantly,
available older children and adults were assessed in
2009 (n = 800), 2011 (n = 795), and 2012 (n = 1812)
Fig. 1 Time line of treatment, EVAL, and monitoring. The years in which MDA and EVAL surveys were performed are shown by the arrows and
times at which monitoring tools in support of EVAL are shown by the + sign
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(Tables 1 and 2). In 2013, testing of older children and
adults was restricted to those who were positive by ICT
in 2012 (n = 50). Although the sizes of the six study
villages differed, the study populations within the villages
were quite well balanced in terms of gender within both
the 6 to 7 year-old children and the ≥ 8 year-olds through-
out the study period (Table 2).
CFA and Wb123 antibody prevalence assessment over the
surveillance period
The CFA prevalence in 6–7 year-old children increased
significantly over the surveillance period, from 0% (0/
289) in 2009 to 2.7% (8/301) in 2011 and 4.5% (14/309)
in 2013 (trend χ2 = 12.80, df = 3, P = 0.0003) (Table 3). In
contrast, there was a significant decrease in CFA positiv-
ity over the study period in the ≥ 8 year-olds, from 4.9%
(39/800) in 2009 to 3.5% (28/795) in 2011, to 2.8% (50/
1,812) in 2012 (trend χ2 = 697.8, df = 2, P = 0.0001).
Whereas none of the ICT-positive 6–7 year-olds had
detectable microfilaraemia, 1 of 39 (2.6%) individuals in
the older group was microfilaraemic in 2009, and 3/36
(8.3%) were microfilaraemic in 2011. In 2012, none of
the 50 ICT-positive older subjects was microfilaraemic
(Table 3). Forty-four of the previously ICT-positive older
subjects, as well as 6 of the 6–7 year-olds who were
ICT-positive and 8 years old at the time of the 2013 sur-
vey, were reassessed in 2013. None of the 28 subjects
who remained ICT-positive in 2013 had detectable
microfilaraemia (data not shown). Positivity rates for
both the Og4C3 ELISA for CFA and testing for anti-
bodies to the W. bancrofti-specific antigen, Wb 123,
were similar to the results obtained using the ICT tests
(χ2 = 3.52, df = 2, P = 0.173).
Entomological assessment
The number of mosquitoes collected using the HLC
over the study period is detailed in Table 4. The highest
ABR using the HLC was 374 bites per person in 2012
and the lowest was in 2011 with 155 bites per person.
Among the dissected mosquitoes, the parity rates were
significantly different between the 3 yearly entomological
surveys with 84% (3,675/4,380) in 2009, 84% (2,406/
2,853) in 2011 and 88% (5,032/5,718) in 2012 (χ2 =
40.76, df = 2, P <10-4). In 2009, two (0.05%) filaria-
infected Anopheles females were detected (Table 4) with-
out any infective larval stage recovered. In 2011 and
2012, no W. bancrofti larvae were found in the dissected
mosquitoes (data not shown).
With the PSC method during the 6 months of collec-
tion in 2012, 1907 mosquitoes were collected and the
ABR was 100 bites per person per year. The number of
mosquitoes collected with the PSC technique was 3.75
times less than that collected with the HLC in 2012.
Moreover, both the infection and infectivity of the PSC-
collected mosquitoes were 0 (Table 4). Of note, An.
gambiae complex was the most frequent vector compris-
ing more than 99% of the active vector fauna each year
as compared to An. funestus complex (data not shown).
We observed the highest vector density (12 mosqui-
toes per person per night) in 2012 with 7165 mosquitoes
collected by 576 collectors. This density was 2.4 times
higher than that in 2011 (2962 mosquitoes) and 1.6
times more than that in 2009 (4448 mosquitoes). Of the
2962 and 7165 mosquitoes collected in 2011 and 2012,
respectively, the frequencies of An. pharaoensis varied
from 1.31% in 2011 to 0.32% in 2012 while the frequen-
cies of An. rufipes varied from 0.30% in 2011 to 0.01% in
2012. These species were very rare during the previous
collection years in this area and were never found to be
infected with W. bancrofti (Table 4).
Discussion
The current study investigated the LF transmission pat-
terns following cessation of MDA during the surveillance
period from 2009 to 2013 in six neighbouring previously
highly LF endemic villages in the Sikasso region in Mali.
In 2008, after seven rounds of MDA, the W. bancrofti
microfilaraemia and ICT positivity in children (6–7 years)
was reduced to 0%. By 2011 and 2012, the prevalence of
ICT-positivity in 6–7 year-old children showed an in-
crease, although microfilaraemia was not detected. Despite
a steady increase in CFA prevalence in 6–7 year-old chil-
dren, there was a marked decrease in CFA prevalence rates
over the same 5 year period among those ≥ 8 years of age
Table 1 Sampling according to different activities per year
Study human sample Mosquito collection
Year Total population 6–7 years old ≥ 8 years Number collected Technique used Number of collection rounds
2009 4,431 289 800 4,448 HLC 72
2011a 4,761 301 795 2,962 HLC 72
2012 5,044 285 1,812 7,168/1,907 HLC/PSC 72/36b
2013c 5,225 309 50 nd nd nd
Abbreviation: nd not done
aIn 2011, a random sample of 92 subjects from the 6 villages was tested with Wb123 ELISA
bIn 2012, the six villages were visited once a month from July to December (collection in 30 rooms per visit per village)
cIn 2013 the 50 subjects ≥ 8 years tested were the ones found positive using ICT in 2012
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(trend χ2 = 7.361, df = 3, P = 0.0067). This decrease is con-
sistent with attrition over time of established worms. Des-
pite the increasing CFA prevalence in children, our data
are most consistent with interruption of LF transmis-
sion based on the absence of detectable microfilaraemia, the
lack of infective Anopheles, and the decreased CFA preva-
lence in the older age group. Nonetheless, close monitoring
in areas of previously high transmission is necessary to de-
tect early resurgence of transmission and to generate data
that may guide and improve the LF elimination process.
When prevalence was estimated using different tools
(Og4C3 ELISA and Wb123 immunoassays) at a single
time point (2012), ICT consistently gave a higher preva-
lence rate compared to the two other tests, although the
differences in prevalence were not statistically significant.
Higher prevalences using ICT compared to Og4C3 ELISA
was also observed in Togo during a school-based TAS
conducted 3 years after stopping MDA [14], although the
reasons for this are unclear. Loa loa microfilaraemia has
been shown to be associated with ICT-positivity at both
Table 2 Characteristics of the study population per village throughout the surveillance period in the 6 study villages of the Sikasso
district
Village 6–7 years 8 years and above Overall
M/F Total M/F Median age (Range) Total
Survey 1 in 2009
Dozanso 20/29 49 60/73 34 (12–79) 133 182
Missasso 26/20 46 64/94 40 (15–76) 158 204
Gondaga 22/21 43 55/64 33 (12–75) 119 162
Niatanso 30/24 54 91/106 31 (12–69) 197 251
N’Torla 23/16 39 50/49 37 (12–72) 99 138
Zanadougou 28/30 58 31/63 37.5 (13–77) 94 152
Total 149/140 289 351/449 35 (12–79) 800 1,089
Survey 2 in 2011
Dozanso 21/17 38 42/71 32 (15–82) 113 151
Missasso 22/31 53 51/99 35 (15–86) 150 203
Gondaga 21/17 38 58/73 29 (15–84) 131 169
Niatanso 25/29 54 73/60 31 (15–82) 133 187
N’Torla 35/26 61 53/80 31 (15–88) 133 194
Zanadougou 26/31 57 49/86 31 (15–89) 135 192
Total 150/151 301 326/469 38 (15–89) 795 1,096
Survey 3 in 2012
Dozanso 20/16 36 95/137 32 (15–82) 232 268
Missasso 21/27 48 101/171 33 (15–79) 272 320
Gondaga 27/21 48 100/177 28 (15–85) 277 325
Niatanso 26/25 51 134/182 28 (15–83) 316 367
N’Torla 22/15 37 127/208 30 (15–89) 335 372
Zanadougou 34/31 65 137/243 30 (15–80) 380 445
Total 150/135 285 694/1,118 30 (15–89) 1,812 2,097
Survey 4 in 2013
Dozanso 24/24 48 8/15 41 (8–75) 23 73
Missasso 26/21 47 1/4 38 (31–68) 5 52
Gondaga 30/25 55 0/5 28 (8–58) 5 60
Niatanso 32/23 55 1/3 25.5 (8–63) 4 60
N’Torla 18/24 42 1/6 46 (24–66) 7 49
Zanadougou 31/31 62 4/2 29 (8–58) 6 68
Total 161/148 309 15/35 38 (8–75) 50 359
Abbreviation: M/F male/female
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the community and individual levels [15, 16]; however, the
same studies showed no association between ICT-
positivity and the prevalence of M. perstans, the only
other filarial parasite endemic in the study area [17].
Re-emergence of infection after just a few years of
surveillance has been reported in Nigeria in some but
not in all districts [18]. In India after 10 years following
MDA implementation, new infection among children
was also reported [19]. Using 6–7 year-old children as
the sentinel population makes sense in the Malian con-
text because this group remains in the villages, whereas
many adults travel from place to place because of
seasonal migration for agriculture and may acquire in-
fection in areas that have not yet started MDA [20].
The approach to post-MDA surveillance is still be-
ing perfected. Antibody testing (e.g. Wb123) has been
proposed as a potential better tool than antigen test-
ing for the early identification of on-going transmis-
sion, as antibody positivity typically occurs months
prior to positivity in adult antigen-based circulating
antigen testing [21–23]. As there was good concord-
ance between Wb123 prevalence and that of the CFA
testing in the children (see Table 1) and with both tests
now being point of care (POC) [8, 24], it is possible that
the Wb123 rapid diagnostic test may be considered as a
major surveillance tool in the near future.
Although screening of vector populations for the pres-
ence of infective larvae has been one of the 2 pillars of
assessing transmission interruption in onchocerciasis
[25, 26], its widespread use in LF has not taken hold to
date. However, using both standard (dissection) and
molecular techniques on both HLC and PSC collected
mosquitoes (n = 9072) only a few positives were found
(and only just after the cessation of MDA). This is prob-
ably due to the drastic reduction of microfilaraemia
prevalence after the seven consecutive MDA treatments
and to the relatively low number of mosquitoes collected
and the low sensitivity of the dissection [7]. Since RT-
PCR, a more sensitive method to detect infective stage
L3 larvae in the vector, is available [7], screening of
Table 3 Circulating filarial antigen (CFA) and microfilaraemia prevalence rates within 6–7 year-old children and those of 8 years and
above from 2009 to 2013
Survey 1 (2009) Survey 2 (2011) Survey 3 (2012)a Survey 4 (2013)
Sample size and target Targeted sample size 1,107 1,107 2,530 372
Total population 4,431 4,761 5,044 5,225
Number tested (n) 1,089 1,096 2,097 359
ICT ≥ 8 years % Positive (n/N) 4.9% (39/800) 3.5% (28/795) 2.8% (50/1,812)
[95% CI] [3.53–6.67] [2.40–5.12] [2.08–3.65] –
6–7 years % Positive (n/N) 0% (0/289) 2.7% (8/301) 3.9% (11/285) 4.5% (14/309)
[95% CI] [0.00–1.64] [1.24–5.37] [2.04–7.00] [2.60–7.66]
Mf ≥ 8 years % Positive (n/N)b 2.6% (1/39) 10.7% (3/28) 0% (0/50)
[95% CI] [0.06–13.48] [2.81–29.37] [0.00–8.89] –
6–7 years % Positive (n/N)b 0 0% (0/8) 0% (0/11) 0% (0/14)
[95% CI] [0.00–40.23] [0.00–32.15] [0.00–26.76]
PCR ≥ 8 years % Positive (n/N) 5.13% (2/39) np np np
[95% CI] [0.89–18.63]
6–7 years % Positive (n/N) 0 np np np
[95% CI]
Wb123 ≥ 8 years % Positive (n/N) np np 4.7% (2/43) nd
[95% CI] [0.81–17.06]
6–7 years % Positive (n/N) np np 1.8% (5/285) nd
[95% CI] [0.65–4.27]
Og4C3 ≥ 8 years ICT % Positive (n/N) np np 4% (2/50) np
[95% CI] [0.70–14.86]
6–7 years % Positive (n/N) np np 1.8% (5/285) np
[95% CI] [0.65–4.27]
Abbreviations: ELISA enzyme-linked immuno-sorbent assay, ICT immunochromatographic card test, ICT+ ICT positive, Mf microfilaraemia, n number positive,
N number examined, nd not done, np not planned, PCR polymerase chain reaction, Wb123 filarial antibody test
aIn 2012, the ELISA test was done on all the children and the 50 ICT positive adults
bOnly the ICT positive subjects were tested for Mf
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larger numbers of mosquitoes and pool screen-based
molecular techniques will need to be assessed.
The observation that An. pharaoensis and An. rufipes
were more frequently biting humans and their identifi-
cation as secondary vectors of W. bancrofti in West
Africa [27], raises the possibility that transmission can
be sustained by a number of vectors other than the
most prevalent (An. gambiae complex). The rain pat-
tern in 2012 (frequency and abundance) likely played a
role in the increased vector density, as well as in the
increase in An. pharaoensis and An. rufipes frequen-
cies [28, 29]. However, what is needed is an adequately
designed prospective study of W. bancrofti transmis-
sion dynamics and vector control in this region of
Mali. In addition, HLC was much more effective at
collecting Anopheles than PSC; because of potential
ethical issues related to HLC [30], better collection
methods are needed.
With very low human infection and vector infectivity
rates, there is no evidence that W. bancrofti transmission
has re-emerged in the study villages in the present study
[5, 12]. Nevertheless, new entomological studies are
needed to understand transmission dynamics in the con-
text of post MDA surveillance. Mosquito vectors trans-
mit W. bancrofti in two primary patterns, limitation and
facilitation. Limitation is typically exhibited by Culex
species and allows more efficient L3 development when
microfilaraemia loads are low. Conversely, facilitation
(usually exhibited by Anopheles species) leads to de-
creased numbers of developing L3 when microfilaraemia
loads are low. Because limitation of An. gambiae (sensu
stricto) has been observed in Ghana [31], it should also
be assessed in other geographic locations (e.g. Mali)
given the possibility of adaptation or specific mutation
that can modify mosquito’s transmission pattern [32].
From our previous studies, in the same area, WHO
Table 4 Annual variation of mosquito densities and biting rates over the surveillance period from 2009 to 2012






HLC 2009 GA 4,443 4,375 232 3,671 2
98.47 [98.05–98.8] 83.9 [82.78–84.98] 0.05 [0.01–0.18]
FU 5 5 0 4 0
100 [46.29–100] 80 [29.88–98.94]
PH 0 0 0 0 0
RU 0 0 0 0 0
2011 GA 2,911 2,803 152 2,364 0
96.29 [95.52–96.93] 84.34 [82.92–85.65]
FU 3 3 0 3 0
100 [31.00–100] 100 [31.00–100]
PH 39 38 2 30 0
97.44 [84.92–99.87] 78.95 [62.22–89.86]
RU 9 9 1 9 0
100 [62.88–100] 100 [62.88–100]
2012 GA 7,138 5,691 368 5,006 0
79.82 [78.86–80.74] 88.9 [88.05–89.70]
FU 3 3 0 3 0
100 [31.00–100] 100 [31.00–100]
PH 23 23 1 22 0
100 [77.08–100] 94.1 [69.23–99.69]
RU 1 1 0 1 0
100 [5.46–100] 100 [5.46–100]
PSC 2009 nd nd nd nd nd
2011 nd nd nd nd nd
2012 An. spp. 1,907 115a 12b nd 0
Abbreviations: An. spp. Anopheles species, HBR human biting rate, HLC human landing catch, FU Anopheles funestus, GA Anopheles gambiae, PH Anopheles
pharaoensis, PSC Pyrethrum spray catch, RU Anopheles rufipes, nd not done
aNumber of pools of 20 mosquitoes tested with the RT-PCR
bThe number of half gravid and blood fed mosquitoes divided by the number of sleepers in the rooms visited the night before the collection
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criteria were met but the mosquitoes were still infective
(infectivity rate of 0.02%) when the MDA was stopped
[6]. Taking into account the entomological data and
determining a threshold could be beneficial to be able to
safely stop MDA in highly LF endemic areas.
Despite a dramatic and stable decrease in the preva-
lence of infection in the older age groups and in mosqui-
toes 5 years following the cessation of MDA in six
villages previously highly endemic for LF, a significant
increase in the prevalence of LF antigenemia as assessed
by ICT occurred among 6–7 year-old children. Although
the ICT prevalence in this age group met WHO criteria
for restarting MDA (> 2% ICT-positive) [5], the preva-
lence using the Og4C3 ELISA and Wb123 antibody
ELISA were below the threshold. Furthermore, the ob-
served prevalence increase within this group contrasted
with the entomological data that showed an absence of
LF transmission and the absence of microfilaraemia in
all individuals tested.
Conclusions
Using a set of LF testing methods (ICT, Wb123, Og4C3
ELISA, and vector surveillance), we demonstrated differ-
ences among the various techniques considered important
for post-MDA assessments. Our data suggest, neverthe-
less, that an integrated assessment strategy that combines
serologic- and vector-based techniques may be useful in
the assessment of transmission interruption following
cessation of MDA in LF-endemic areas.
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